0001905806-24-000004.txt : 20240112 0001905806-24-000004.hdr.sgml : 20240112 20240112133751 ACCESSION NUMBER: 0001905806-24-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240112 DATE AS OF CHANGE: 20240112 EFFECTIVENESS DATE: 20240112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Grannus Therapeutics, Inc. CENTRAL INDEX KEY: 0001905806 ORGANIZATION NAME: IRS NUMBER: 844009398 STATE OF INCORPORATION: X1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-502310 FILM NUMBER: 24531523 BUSINESS ADDRESS: STREET 1: 7210 N. PENNSYLVANIA STREET CITY: INDIANAPOLIS STATE: IN ZIP: 46240 BUSINESS PHONE: 3174146205 MAIL ADDRESS: STREET 1: 7210 N. PENNSYLVANIA STREET CITY: INDIANAPOLIS STATE: IN ZIP: 46240 FORMER COMPANY: FORMER CONFORMED NAME: Grannus Therapeutics Inc. DATE OF NAME CHANGE: 20220120 D 1 primary_doc.xml X0708 D LIVE 0001905806 Grannus Therapeutics, Inc. 7210 N. PENNSYLVANIA STREET INDIANAPOLIS IN INDIANA 46240 3174146205 UNITED STATES Grannus Therapeutics, LLC Grannus Therapeutics Inc. Corporation true 2020 John Foglesong 7210 N. Pennsylvania St. Indianapolis IN INDIANA 46240 Executive Officer Director Brian Blagg 7210 N. Pennsylvania Street Indianapolis IN INDIANA 46240 Director Biotechnology Decline to Disclose 06b false 2023-11-17 true true false 250000 800000 800000 0 false 9 0 0 0 false Grannus Therapeutics, Inc. /s/ John Foglesong John Foglesong CEO 2024-01-11